# Carboxylesterase 1 Genetic Variation and Methylphenidate in ADHD

> **NCT03781752** · PHASE4 · RECRUITING · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 500 (estimated)

## Conditions studied

- ADHD
- Attention Deficit Hyperactivity Disorder

## Interventions

- **DRUG:** Methylphenidate

## Key facts

- **NCT ID:** NCT03781752
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2018-03-04
- **Primary completion:** 2025-08
- **Final completion:** 2025-08
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2024-08-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03781752

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03781752, "Carboxylesterase 1 Genetic Variation and Methylphenidate in ADHD". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03781752. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*